ArticleLeukemia & lymphoma2022

Second primary malignancy risk after Hodgkin lymphoma treatment among HIV-uninfected and HIV-infected survivors.

Renata Abrahão et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.